{"classes":[{"categories":[{"measurements":[{"comment":"The upper limit of the 95% confidence interval could not be estimated due to the small number of patients who had an objective response.","groupId":"OG000","lowerLimit":"5.62","upperLimit":"NA","value":"7.6"},{"groupId":"OG001","lowerLimit":"5.65","upperLimit":"9.66","value":"7.6"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"27"}],"units":"Participants"}],"description":"Duration of OR was defined as the time from the initial CR or PR to the earliest documented disease progression (PD) or death. Metastatic BCC - PD: ≥ 20% increased sum of the longest diameter (SLD) of targets from nadir, or 1 or more new lesions. Locally advanced BCC - PD: any of: (1) ≥ 20% increased SLD from nadir (radiography or externally visible dimension); (2) new ulceration; (3) new lesions (radiography or physical exam); (4) progression of non-target lesions by radiography.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients received vismodegib 150 mg orally once daily until disease progression; intolerable toxicity, most probably attributable to vismodegib; or withdrawal from the study.","id":"OG000","title":"Metastatic Basal-Cell Carcinoma"},{"description":"Patients received vismodegib 150 mg orally once daily until disease progression; intolerable toxicity, most probably attributable to vismodegib; or withdrawal from the study.","id":"OG001","title":"Locally Advanced Basal-Cell Carcinoma"}],"paramType":"MEDIAN","populationDescription":"Efficacy-evaluable population: All treated patients for whom the independent pathologist's interpretation of archival tissue or baseline biopsies was consistent with basal cell carcinoma.","reportingStatus":"POSTED","timeFrame":"From initial OR until the earliest documented disease progression (PD) or death (until clinical cutoff date of 26 November 2010, up to 90 weeks)","title":"Duration of Objective Response (OR) Determined by the Independent Review Facility","type":"SECONDARY","unitOfMeasure":"Months"}